Cyto-Matrix Peak EPA

High dose and molecularly distilled omega-3 fatty acids for improved patient compliance: 700mg of EPA and 350mg of DHA in each softgel.

EPA and DHA have been clinically studied in a variety of health conditions. For example, supplementation with these omega-3 fatty acids have been found to be beneficial for maintaining cardiovascular health, rheumatoid arthritis, autoimmunity, cognition, mood, skin health and atopic concerns, to name just a few clinical indications. Simply put, EPA and DHA should be considered for any systemic inflammatory condition.

One challenge that arises with omega-3 fatty acid supplementation is poor compliance. Most supplements require many capsules or teaspoons per day to achieve an evidence-based dose of EPA and DHA. Cyto·Matrix’s Peak·EPA solves this problem by providing 700mg of EPA and 350mg of DHA in a single softgel. These omega-3 fatty acids, sourced from wild deep sea fish, are found in the well-researched ethyl ester form, allowing for evidence-based, extremely concentrated and cost-effective delivery.

• Each softgel delivers a minimum of 700mg EPA and 350mg DHA, sourced from wild deep sea fish
• Molecularly distilled to ensure the end product is free from heavy metals, organophosphate compounds and unwanted contaminants
• Lightly flavoured with food grade essential oil of lime
• Indicated for systemic inflammatory conditions such as rheumatoid arthritis, autoimmunity, cognitive decline, eczema and atopic concerns